DRUGS & THERAPY PERSPECTIVES
ISSN:1172-0360

DRUGS & THERAPY PERSPECTIVES

DRUGS THER PERSPECT
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:-
新锐分区:医学4区
年发文量:74
影响因子:0.7
JCR分区:Q4

基本信息

Drugs & Therapy Perspectives通过发表简洁、权威的综述文章来帮助制定药物处方和治疗决策,并发表涵盖药物治疗各个方面的原创研究文章来帮助医疗保健专业人员提供高质量的患者护理,从而促进合理的药物治疗和有效的疾病管理。它侧重于研究的实际应用和在现实世界临床环境中工作的医疗保健专业人员的最佳证据。该杂志包括:药物制剂,疾病管理,药物不良反应和相互作用,或其他临床相关问题的审查。这些提供了在现实世界中使用药物制剂的最新指南,包括逐步的患者护理指南,以帮助治疗决策,以及药物的差异特征,使处方集比较。原创研究文章,重点放在临床实践和现实世界的结果,以帮助医疗保健专业人员提供优质的循证患者护理。治疗实践文章,就新出现的问题和特定疾病或治疗问题的治疗方法提供国际观点的最新意见和评论。其他数字功能(包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画)可与文章一起发表;目的是提高刊物的知名度、读者群和教育价值。此外,在《药物与治疗展望》上发表的文章可能会附有简明扼要的摘要,以帮助对该领域有一定了解但没有深入专业知识的读者了解重要的医学进展。所有稿件均需经过国际专家的单盲同行评审。欢迎给编辑写信,并将考虑出版。
1172-0360ESCI/Scopus收录
0.7
0
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:PHARMACOLOGY & PHARMACY
ESCI
Q4
324/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:PHARMACOLOGY & PHARMACY
ESCI
Q4
324/353
暂无h-index数据
74
----PHARMACOLOGY & PHARMACY-
0%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
18.92%11.62%-
CiteScore:1.00
SJR:0.232
SNIP:0.194
学科类别分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q4
214 / 275

期刊高被引文献

High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00643-7
Utilization, availability of analgesics and quality of pain control for post-operative pain in surgical patients
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-0582-3
Fexinidazole in human African trypanosomiasis: a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00672-2
Understanding system-focused barriers to the identification and reporting of medication errors and adverse drug events in emergency medical services
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00628-6
Assessment of anticoagulation management in outpatients attending a warfarin clinic in Windhoek, Namibia
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00630-Y
Adverse events and monitoring requirements associated with monoclonal antibody therapy in patients with multiple sclerosis
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00682-0
Insulin glargine/lixisenatide in type 2 diabetes: a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00670-4
Appropriateness of postoperative analgesic doses among pediatric surgical patients in a teaching hospital in Northwest Nigeria
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00604-0
Avatrombopag in the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure: a profile of its use in the USA
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-0593-0
Health-related quality of life and associated factors in patients with chronic obstructive pulmonary disease
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00617-9
Ivosidenib in relapsed or refractory acute myeloid leukemia: a profile of its use in the USA
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00610-2
Erenumab in the prophylaxis of migraine: a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-0589-9
Ertugliflozin in type 2 diabetes: a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00651-7
Revisiting clinical practice in therapeutic drug monitoring of first-generation antiepileptic drugs
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00662-4
Midazolam oral solution (Ozalin®): a profile of its use for procedural sedation or premedication before anaesthesia in children
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00629-5
No difference in relevant potential allergens in SPF-containing facial moisturizers: implications in frontal fibrosing alopecia
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00636-6
Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00646-4
When managing ulcerative colitis in older patients, understanding their overall health profile is key
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00647-3
Encorafenib + binimetinib: a profile of their combined use in treating BRAF-mutated unresectable or metastatic melanoma
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00609-9
Effect of GSTP1 polymorphism on efficacy and safety of cyclophosphamide aggressive therapy in lupus nephropathy patients
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00631-X
The use of medicines in exceptional circumstances in Spain: adding perspective to early access
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-018-0590-3
Correction to: Ivosidenib in relapsed or refractory acute myeloid leukemia: a profile of its use in the USA
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00645-5
Correction to: Midazolam oral solution (Ozalin®): a profile of its use for procedural sedation or premedication before anaesthesia in children
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00641-9
Association between variants of COQ2 and TNF-α genes and statin-induced toxicities in Bangladeshi hyperlipidemic patients
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00677-x
Correction to: Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-00596-3
Exenatide extended-release pre-filled pen (Bydureon® BCise®): a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-00597-2
Corticosteroid pulse therapy-associated aseptic humeral and femoral head necrosis: a case report
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00620-0
Identify potentially inappropriate medications in older adults with chronic kidney disease and deprescribe when possible
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00639-3
Intranasal esketamine in treatment-resistant depression: a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00675-z
Aim to normalize glucose levels and reduce cardiovascular mortality when managing type 2 diabetes in the elderly
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00619-7
Be aware of the risk of drug-induced kidney stones and take appropriate steps to prevent or treat their occurrence
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-0565-4
Severe skin rash associated with efavirenz and atazanavir: a case report in a rural health facility in Kenya
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-0569-0
Treat childhood vitiligo with topical corticosteroids, topical calcineurin inhibitors and/or targeted phototherapy
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00660-6
Fluticasone propionate/salmeterol (Wixela® Inhub®) dry-powder inhaler in asthma and COPD: a profile of its use in the USA
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00686-w
The use of fluoroquinolones and macrolides for sinusitis: a retrospective cross-sectional study
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00652-6
Manage motor fluctuations in Parkinson’s disease by taking a hierarchical approach and individualizing treatment
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00616-W
Interventions to assist parents and caregivers in accurately dosing liquid medications for their children: a scoping review
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00615-X
Increasing lithium concentration despite extracorporeal treatment: a case report
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00624-W
Elagolix in endometriosis-related pain: a profile of its use as approved in the USA
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00606-Y
When managing atopic dermatitis-related itch, use a step-wise approach, address barrier repair and educate patients
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-0570-7
A critical review of pyritinol
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00623-X
Correction to: K-haler® breath-triggered inhaler: a profile of the properties of the device
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00656-2
Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00654-4
Manage endometriosis-related pain with hormonal suppression therapies
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00601-3
Manage drug-induced dry mouth with drug regimen changes, lifestyle interventions and topical or oral symptom-relieving products
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00618-8
Management of atherogenic dyslipidemia according to current treatment guidelines: DESPEGA study in real clinical practice
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00605-Z
Correction to: Carglumic acid in hyperammonaemia due to organic acidurias: a profile of its use in the EU
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00608-W
Correction to: Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-018-0587-Y
Correction to: “Correction to: Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use”
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/S40267-019-00613-Z
Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: an open-label randomised controlled trial
来源期刊:Drugs & Therapy PerspectivesDOI:10.1007/s40267-019-00621-z

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区